Objective: To determine whether measures of heart rate variability are related to changes in temperature during rewarming after therapeutic hypothermia for hypoxic-ischemic encephalopathy. Design: Prospective observational study. Setting: Level 4 neonatal ICU in a free-standing academic children's hospital. Patients: Forty-four infants with moderate to severe hypoxic-ischemic encephalopathy treated with therapeutic hypothermia. Interventions: Continuous electrocardiogram data from 2 hours prior to rewarming through 2 hours after completion of rewarming (up to 10 hr) were analyzed. Measurements and Main Results: Median beat-to-beat interval and measures of heart rate variability were quantified including beat-to-beat interval sd, low and high frequency relative spectral power, detrended fluctuation analysis short and long α exponents (α S and α L ), and root mean square short and long time scales. The relationships between heart rate variability measures and esophageal/axillary temperatures were evaluated. Heart rate variability measures low frequency, α S , and root mean square short and long time scales were negatively associated, whereas α L was positively associated, with temperature (p < 0.01). These findings signify an overall decrease in heart rate variability as temperature increased toward normothermia. Conclusions: Measures of heart rate variability are temperature dependent in the range of therapeutic hypothermia to normothermia. Core body temperature needs to be considered when evaluating heart rate variability metrics as potential physiologic biomarkers of illness severity in hypoxic-ischemic encephalopathy infants undergoing therapeutic hypothermia. (Pediatr Crit Care Med 2017; 18:349-354) 
H ypoxic-ischemic encephalopathy (HIE) resulting from acute perinatal asphyxia is a significant cause of neurodevelopmental disability in term infants (1, 2) . Therapeutic hypothermia (TH) has been demonstrated to improve outcomes and has become the current standard of care (3, 4) . However, nearly half of infants with moderate to severe HIE continue to suffer death or disability despite treatment with cooling (3). Current and future investigations will focus on identifying adjuvant neuroprotective therapies to further improve outcomes in newborns with HIE. However, monitoring adequate therapeutic response acutely and identifying HIE infants in need of alternate treatments remains clinically challenging. Clinicians need readily accessible real-time biomarkers of disease progression to better guide potential interventions and aid in therapeutic decisions.
The quantitative analysis of cardiac beat-to-beat intervals (RRi) has been increasingly recognized as a convenient means for bedside physiologic assessment of the critically ill infant. A growing body of research supports the use of quantitative measures of RRi variability (i.e., heart rate variability [HRV] ) as a noninvasive tool for early detection of autonomic dysfunction Division of Fetal and Transitional Medicine, Children's National Health System, Washington, DC. 3 Pediatric Residency Program, Children's National Health System, Washington, DC. 4 Division of Biostatistics and Study Methodology, Children's National Health System, Washington, DC. 5 The George Washington University School of Medicine, Washington DC. 4, 5 and clinical deterioration in infants (5) (6) (7) (8) . More recently, we and others have reported that HRV metrics may be used to stratify HIE newborns by severity (9, 10) and identify infants who are at greatest risk for death or severe MRI brain injury (11) or neurodevelopmental impairment (12, 13) . Thus, the use of HRV holds promise as a physiologic biomarker to guide management of newborns with HIE.
Although standards have been proposed for evaluating HRV in adult patients (14) , recent methodologic advances have allowed for characterization of HRV via alternative methods (15). We previously described novel methods to quantify HRV in newborns via advanced signals processing approaches including frequency domain-based spectral analysis (SA) and time domain-based detrended fluctuation analysis (DFA), a method stemming from the concept of statistical physics (16, 17) . These methods can account for nonstationarity common in critically ill patients in the ICU setting and have been adapted to the unique physiology observed in the newborn. These methods can offer additional measures to characterize features of HRV beyond traditional statistics such as sd of the RRi (SDNN). SA relative low frequency (LF) power quantifies predominantly the sympathetic tone, whereas the high frequency (HF) power band quantifies the parasympathetic (vagal) tone of the autonomic nervous system (ANS) (18, 19) . The DFA root mean square (RMS) fluctuation and α exponents quantify the variability and autocorrelations in the RRi, respectively, in short (s) and long (L) time scales (RMS S and RMS L ). α S , RMS S , and RMS L reflect the sympathetic tone of the ANS, whereas α L characterizes slow (2.5 min) changes in heart rate (17, 20) . These metrics can be quantified in real-time to allow for automated evaluation of continuous electrocardiogram (ECG) data, a requisite feature for a viable bedside tool.
However, before advancing HRV into more widespread validation and ultimately bedside use, potential clinical confounders that may affect HRV in the setting of hypothermia must be better understood. Although sinus bradycardia during cooling and mild hypotension due to vasodilation during rewarming are known cardiovascular side effects of TH (21) (22) (23) , the effect of TH on specific HRV metrics has not been fully characterized. This is important as animal data (24, 25) , and studies in adults (26) (27) (28) (29) and preterm infants (30) suggest an association between HRV measures and temperature. On the basis of these prior studies, it was hypothesized that HRV metrics would be significantly associated with changes in core body temperature during rewarming in newborns after TH.
MATERIALS AND METHODS

Study Population
Newborns enrolled in this study were part of an ongoing prospective study evaluating physiologic and biochemical biomarkers of brain injury in babies with HIE. Infants were treated with whole-body hypothermia according to the National Institute of Child Health and Human Development (NICHD) Neonatal Research Network protocol, with inclusion criteria according to established NICHD criteria (i.e., infants were > 36-wk gestational age, > 1,800 g at birth, demonstrated metabolic acidosis and/or low Apgar scores, and exhibited signs of moderate to severe clinical encephalopathy) (3). Infants were passively cooled during transport and then initiated on active cooling immediately upon arrival to the neonatal ICU (NICU). Infants were maintained at a target temperature of 33.5°C using the Blanketrol II cooling unit (Cincinnati SubZero, Cincinnati, OH) for 72 hours, followed by rewarming by 0.5°C per hour over 6 hours to normothermia (36.5°C). The study was approved by the Children's National Health System Institutional Review Board. Informed consent and Health Insurance Portability and Accountability Act Authorization were obtained from the parent of the participant.
Data Collection
Demographic and clinical data were collected from birth hospital and NICU medical records. Continuous recordings of ECG from the NICU bedside cardiorespiratory monitor (Philips IntelliVue MP70; Philips Healthcare, Andover, MA) were collected prospectively in a time-locked manner at a rate of 500 Hz and up-sampled to 1 kHz using custom software developed in LabView (National Instruments, Austin, TX). For newborns not enrolled within 24 hours of life, ECG data were collected if available from an institutional Research Data Export (RDE) archive (IntelliVue Information Center; Philips Healthcare). ECG data from 2 hours prior to rewarming through 2 hours after completion of rewarming (a total of 10 hr) were analyzed. Serial hourly measurements of core body temperature from the esophageal temperature probe (Steri-probe; Cincinnati Sub-Zero, Cincinnati, OH) were recorded. If esophageal temperatures were not documented, then axillary temperatures were used. If more than one temperature was recorded for a given hour, then the values were averaged.
ECG Signal Preprocessing
Signal processing was done using MATLAB (Mathworks, Natick, MA) as previously described (12, 16) . Briefly, after the data were bandpass filtered between 0.5 and 70 Hz, and semiautomated artifact rejection applied, the R-wave was identified using adaptive Hilbert transform approach (31, 32) . For SA, the RRi was converted into evenly sampled data using cubic-spline interpolation at a sample rate of 4 Hz. The data were divided into 10-minute windows for calculation of HRV metrics.
HRV Metrics
HRV metrics were calculated within each 10-minute window according to established methods using traditional statistics and advanced signal processing approaches in the frequency and time domains. The median value of the HRV metrics calculated within a given hour was used for statistical analyses.
Traditional Statistics. The median and SDNN were calculated within each 10-minute window. The median RRi is a quantitative measure of heart rate, whereas the SDNN is a measure of HRV.
Frequency Domain-SA. In each 10-minute window, the power spectrum was estimated via previously described methods (12, 16) . The relative LF and HF power were analyzed as measures of ANS regulation of HRV (18, 19) . The LF power was calculated as the sum of power in the frequency bands covering 0.05-0.25 Hz (30, (33) (34) (35) , whereas HF power was calculated as the sum of power in the frequency bands covering 0.3-1 Hz (30, (33) (34) (35) (36) . Both LF and HF power were divided by the total power (sum of power in the frequency bands covering 0.05-2 Hz) to calculate the relative LF and HF power. These frequency bands were selected to quantify the respiratory oscillations in the heart rate of neonates as previously described (30, 34, 35) .
Time Domain-DFA. DFA metrics were also calculated in each 10-minute window as previously described (17) 
Statistical Analysis
Descriptive statistics included means (sds) and medians (ranges) for continuous parametric and nonparametric variables, respectively, as well as counts (percentages) for categorical data. Since the dependent (HRV metrics) and independent variables (temperatures) included repeated measures for each patient, random effect regression models were used to take into account the intra-subject covariance. HRV data were log transformed to satisfy the normality assumption. Secondary models were also developed to adjust for patient characteristics including birth weight, gestational age, gender, encephalopathy grade (3, 37) at presentation, presenting pH, and the presence of hypotension (defined as the need for vasopressor medications during TH). Sensitivity analyses were also performed considering only esophageal temperatures and stratifying by grade of encephalopathy to evaluate the consistency of results. Statistical analysis was performed using SAS 9.3 (SAS Institute, Cary, NC).
RESULTS
A total of 51 patients with moderate to severe HIE were enrolled. Data were unavailable for seven patients, because they either died after withdrawal of care prior to completion of TH (n = 6) or ECG data were not able to be retrieved from the RDE archive (n = 1). Thus, ECG and temperature data from 44 newborns with HIE were analyzed. The majority (n = 34) were prospectively monitored, while ten patients' ECG data were retrieved from the RDE archive. Characteristics of the study population are described in Table 1 . Patients with unavailable data were similar to the study population with regard to baseline and clinical characteristics (p > 0.05). The median (interquartile range) duration of ECG recording per subject was 8 (2) hours, providing 343 observations for analyses. Reduced models with only esophageal temperatures included 190 observations.
Traditional Statistics
As expected, heart rate increased (median RRi decreased) with increasing temperature (Fig. 1) . This relationship remained significant after adjusting for covariates ( Table 2 ). The SDNN was not significantly associated with temperature (p > 0.05).
Frequency (SA) and Time (DFA) Domain HRV Metrics
A summary of the regression models is presented in Table 2 . Temperature was negatively associated with LF Power, α S , RMS S , and RMS L , and these relationships remained significant after controlling for covariates (p < 0.01). Encephalopathy grade was also negatively associated with these HRV metrics (signifying reduced 
Secondary Sensitivity Analyses
Relationships between HRV metrics and temperature remained consistent when considering only esophageal temperatures, except for α S which remained negatively associated with temperature although this relationship did not reach statistical significance in the reduced models (Table 2) . Although the interaction between encephalopathy grade and temperature was not significant, we proceeded with analyses after stratifying by encephalopathy grade to assess the impact of this important confounder. Infants with moderate encephalopathy showed similar relationships between HRV and temperature as the overall cohort. Although only eight patients had severe encephalopathy, significant associations between median RRi (estimate, -0.045; p = 0.009) and RMS S (estimate, -0.148; p = 0.007) were observed in these patients.
DISCUSSION
This is the first clinical study to evaluate the relationship between HRV and temperature in newborns undergoing TH. Across the range of temperatures observed during the rewarming period, we demonstrate a significant relationship between several HRV metrics and temperature. Specifically, we observed an overall reduction in HRV as temperature increased toward normothermia. This has important implications as the use of HRV as a viable biomarker of disease severity has been recently proposed in several studies (11) (12) (13) . In particular, we recently demonstrated that a key period during the temporal evolution of HRV in newborns with HIE coincided with the rewarming period (12) . The current study underscores the importance of accounting for temperature in future analyses, to be sure that this observation reflects the disease evolution of HIE rather than changes in core temperature over the rewarming process. Although prior studies have consistently shown reduced HRV in HIE newborns with poor outcomes (9-13), the mechanisms for this observation have not been fully elucidated. Decreased HRV may be attributable to direct subcortical or brainstem injury leading to autonomic dysfunction (38) , the effects of asphyxia on the cardiovascular system (22) , the presence of seizures (39-41), or likely a combination of these and other factors. As studies move forward toward more large-scale validation of HRV as a bedside biomarker in HIE, understanding potential confounding factors that can influence HRV under different clinical circumstances is crucial. Our study suggests that temperature variation in the moderate hypothermia range is a factor influencing HRV that needs to be addressed in future studies.
Several studies in adults have suggested a relationship between HRV and both ambient (27) and core body temperature (26, 28, 29) . Studies in healthy preterm and term infants have focused on elevations in ambient temperature and its effect on HRV as a possible etiology for sudden infant death syndrome (30, 42) . These prior studies have highlighted the complexity of the association between temperature and HRV, with one study describing nonlinear relationships and inverse patterns at temperature extremes (26) . Few studies have investigated temperature effect on HRV in the setting of TH. Tiainen et al (28) reported increased HRV in adults undergoing hypothermia after cardiac arrest. Only one small study involving two newborns undergoing TH for HIE likewise reported a negative association between LF power and temperature (33) . These investigators also found a negative association between HF power and temperature as well as a positive association between LF-to-HF ratio and temperature. We did not evaluate LF-to-HF ratio as recent reports have questioned whether this measure accurately reflects the sympathovagal balance as originally proposed (43) . That we did not find a significant relationship between temperature and HF power may be attributable to the observation that HF power is less dynamic and appears to have less overall variability during this time period in newborns with HIE (12) . This may also explain why no association was observed between RRi sd and temperature, as RRi sd provides an overall gross measure of variability rather than evaluating the contributions of specific inputs (e.g., sympathetic or parasympathetic) that may have differential relationships with temperature. To our knowledge, this is the largest study to date evaluating the relationship between HRV metrics and temperature in newborns undergoing cooling. Our findings of increased HRV at lower temperatures are consistent with prior animal (25) and human studies (28, 29, 33) evaluating HRV in the temperature range of moderate TH. The temperature dependency of HRV may be explained via several possible mechanisms. As HRV has been described to be inversely related to heart rate (44), the change in HRV may be attributable to the relationship between heart rate (median RRi) and temperature alone. Alternatively, there may be direct effects of hypothermia on the myocardium that preserve HRV (25, 28) . Finally, it is also possible that the reduction in HRV over the rewarming process reflects withdrawal of the therapeutic effect of hypothermia and may signify a potential benefit for continued hypothermia in some patients. Irrespective of the mechanisms by which body temperature interacts with HRV, our study supports that this relationship exists and may represent a clinically relevant covariate when considering HRV as a physiologic biomarker in neonates undergoing TH. Incorporation of patient temperature may be important as future HRV monitoring paradigms are developed for bedside application.
Several limitations of our study must be recognized. Not all patients contributed 10 hours of continuous data as some recordings were stopped due to clinical reasons. RDE retrieved data were incomplete for the time period of interest, or segments were excluded due to artifact. Although this may be a potential source of bias, the large number of observations provided by a continuous dataset mitigated any impact these missing data may have had on sample size for analyses. Although artifact in the ECG recordings could also impact results, our analytical approach incorporated a robust automated artifact rejection method (16) . Finally, we collected temperature data from the medical record. This allowed for limited resolution (hourly) and the need to consider both esophageal and axillary temperatures for more complete and unbiased data. Although a recent study suggested that axillary temperatures have limited correlation with core temperature in babies undergoing hypothermia (45) , axillary temperature remains the mainstay of temperature monitoring in newborns (46, 47) and has been reasonably correlated to core temperature in other studies (48, 49) . Our results were similar when considering only available esophageal temperatures. Consistency of findings across these two analyses provides confidence in the relationships observed between temperature and HRV. Likewise, our sample size limited our ability to clearly elucidate the relationship between HRV metrics and temperature in infants with severe encephalopathy. Future studies are needed (and planned) with higher resolution core temperature data to further evaluate the relationship between temperature and HRV metrics in babies with moderate to severe HIE.
